Joachim Wolf1, Anton Safer2, Johannes C Wöhrle3, Frederick Palm4, Wilfred A Nix5, Matthias Maschke6, Armin J Grau4. 1. Department of Neurology, Klinikum der Stadt Ludwigshafen, Germany. Electronic address: Wolfj@klilu.de. 2. Institute of Public Health, Medical Faculty, Ruprecht-Karls-University, Heidelberg, Germany. 3. Department of Neurology, Katholisches Klinikum, Brüderhaus, Koblenz, Germany. 4. Department of Neurology, Klinikum der Stadt Ludwigshafen, Germany. 5. Department of Neurology, Universitätsmedizin, Mainz, Germany. 6. Department of Neurology, Krankenhaus der Barmherzigen Brüder, Trier, Germany.
Abstract
OBJECTIVES: The clinical spectrum of amyotrophic lateral sclerosis (ALS) is characterized by a considerable variation. Different phenotypes have been described by previous studies. We assessed clinical variability and prognostic relevance of these phenotypes in a prospective, population-based cohort of ALS patients in Rhineland-Palatinate, Germany. METHODS: Incident ALS cases, diagnosed between October 2009 and September 2012, were prospectively enrolled and classified according to established ALS phenotype classification (bulbar, classic, flail arm, flail leg, pyramidal, respiratory). Survival probability was described using Kaplan-Meier method. Moreover, the influence of an additional frontotemporal dementia (FTD) was analysed. RESULTS: Phenotypes of all 200 patients were determined. Bulbar and classic phenotypes accounted for 75% of all cases. Deterioration of functional impairment during disease progression was lowest in flail leg and pyramidal variants, and most pronounced in bulbar and classic phenotypes. A poor survival prognosis was observed for bulbar, classic or respiratory phenotypes. Patients with an additional FTD showed an even worse outcome. CONCLUSIONS: Results suggest that ALS is a heterogeneous disease, as ALS phenotypes differ in disease progression and survival time. Patients classified as suffering from bulbar, classic and respiratory ALS, as well as those with an additional FTD, show a marked reduction of survival time.
OBJECTIVES: The clinical spectrum of amyotrophic lateral sclerosis (ALS) is characterized by a considerable variation. Different phenotypes have been described by previous studies. We assessed clinical variability and prognostic relevance of these phenotypes in a prospective, population-based cohort of ALSpatients in Rhineland-Palatinate, Germany. METHODS: Incident ALS cases, diagnosed between October 2009 and September 2012, were prospectively enrolled and classified according to established ALS phenotype classification (bulbar, classic, flail arm, flail leg, pyramidal, respiratory). Survival probability was described using Kaplan-Meier method. Moreover, the influence of an additional frontotemporal dementia (FTD) was analysed. RESULTS: Phenotypes of all 200 patients were determined. Bulbar and classic phenotypes accounted for 75% of all cases. Deterioration of functional impairment during disease progression was lowest in flail leg and pyramidal variants, and most pronounced in bulbar and classic phenotypes. A poor survival prognosis was observed for bulbar, classic or respiratory phenotypes. Patients with an additional FTD showed an even worse outcome. CONCLUSIONS: Results suggest that ALS is a heterogeneous disease, as ALS phenotypes differ in disease progression and survival time. Patients classified as suffering from bulbar, classic and respiratory ALS, as well as those with an additional FTD, show a marked reduction of survival time.
Authors: Christian Lunetta; Andrea Lizio; Eleonora Maestri; Valeria Ada Sansone; Gabriele Mora; Robert G Miller; Stanley H Appel; Adriano Chiò Journal: JAMA Neurol Date: 2017-06-01 Impact factor: 18.302
Authors: Feng Tian; Wenlong Yang; Daniel A Mordes; Jin-Yuan Wang; Johnny S Salameh; Joanie Mok; Jeannie Chew; Aarti Sharma; Ester Leno-Duran; Satomi Suzuki-Uematsu; Naoki Suzuki; Steve S Han; Fa-Ke Lu; Minbiao Ji; Rosanna Zhang; Yue Liu; Jack Strominger; Neil A Shneider; Leonard Petrucelli; X Sunney Xie; Kevin Eggan Journal: Nat Commun Date: 2016-10-31 Impact factor: 14.919
Authors: Kaila L Stipancic; Yana Yunusova; Thomas F Campbell; Jun Wang; James D Berry; Jordan R Green Journal: Front Neurol Date: 2021-06-16 Impact factor: 4.003